Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Rat apoA-IV biosynthesis data do not alter lipid management; leaves open human processing and therapeutic relevance.
Total cellular RNA, isolated from rat intestinal epithelium, was translated in a wheat germ cell-free system, and the primary translation product of apolipoprotein A-IV mRNA was purified by immunoprecipitation with monospecific antibody. NH2-terminal sequence analyses of mature rat plasma high density lipoprotein-associated A-IV and the cell-free product revealed that A-IV is initially synthesized with a 20-amino-acid NH2-terminal extension. Co-translational cleavage of the primary translation product indicated that the entire NH2-terminal extension behaved as a prepeptide. The prepeptides of intestinal apolipoproteins A-I and A-IV have 59% sequence homology. However, A-IV does not possess the unusual propeptide previously identified in intestinal A-I (Gordon, J. I., Smith, D. P. Andy, R., Alpers, D. H. Schonfeld, G., and Strauss, A. (1982) J. Biol. Chem. 257, 971-978). Therefore it appears that proteolytic processing of these two apolipoproteins differs significantly.
No takes yet. Share an insight, caveat, or question.
Gordon et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: